Article · 8 Apr 2026
ArticlePublished 2 Jun 2023
Development of validated stabilityindicating chromatographic method for the determination of nebivolol and valsartan and
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A simple, economical, precise, and selective Reverse gradient Phase High-Performance Liquid Chromatography (RP-HPLC) method has been validated and developed to estimate related impurities of Nebivolol (NEB) and Valsartan (VAL) in a tablet dosage form. A RP-HPLC analysis was performed on Hypersil BDS C18 column, and its size was 250 mm × 4.6 mm, 5 μm with using mobile phase Acetonitrile and Potassium dihydrogen phosphate (KH2PO4) with buffer pH-3.0 in the ratio of (50:50) at 282 nm detection wavelength with the flow rate of 1.0 mL/min. The analytical method was validated according to International Council for Harmonisation (ICH) guidelines. The linearity was observed in the Limit of 25-75 μg/ml range for Nebivolol and 1-15 μg/ml range for its related impurity A and B. Similarly, the 400-1200 μg/mL range was observed linearity for Valsartan. The correlation coefficient was more than 0.990 for Nebivolol, its related impurity A and B and Valartan. The % recovery value was found to be a minimum of 101.05% and a maximum of 102.07% for Nebivolol impurity A. Similarly, the % recovery value was found to be a minimum of 100.36% and a maximum of 100.87% for Nebivolol impurity B. The relative standard deviation value for repeatability, interday precision, and intraday precision was less than 5%. The Limit of Detection (LoD) value was found to be 0.017 μg/mL for Nebivolol, 0.378 μg/mL for its related impurity A and 0.071 μg/mL for its related impurity B. The LoD value was found 3.240 μg/mL for Valsartan. The LoQ value was found at 0.051 μg/ mL for Nebivolol, 1.147 μg/mL for its related impurity A and 0.216 μg/mL for its related impurity B. The LoQ value was found 9.820 μg/mL for Valsartan. The proposed method was found to be specific, linear, sensitive, precise, accurate, and robust in nature.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Systematic Reviews in Pharmacy.
Article · 30 Sep 2025
AI?IoT Integration: Balancing Innovation and Compliance in Pharmaceutical Manufacturing
Article · 18 Aug 2025
Investigation of microbiological and organoleptic properties of bee products (bee venom, solid pollen, and royal jelly) through water activity quantification during 8 days of storage
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalSystematic Reviews in Pharmacy
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Vaishali Gohel”
- BylineArticles whose byline prints “Sejalben Patel”
- BylineArticles whose byline prints “Ujashkumar Shah”